Cargando…

Asthma control in adolescents: role of leukotriene inhibitors

Asthma is a chronic inflammatory disease of the airways and is a big burden worldwide. It affects both children and adults, but it is insufficiently studied in adolescents, although this age group has important peculiarities and is challenging to treat, due to, but not exclusively because of, lack o...

Descripción completa

Detalles Bibliográficos
Autores principales: Giavi, Stavroula, Papadopoulos, Nikolaos G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915976/
https://www.ncbi.nlm.nih.gov/pubmed/24600268
http://dx.doi.org/10.2147/AHMT.S7600
_version_ 1782302646119432192
author Giavi, Stavroula
Papadopoulos, Nikolaos G
author_facet Giavi, Stavroula
Papadopoulos, Nikolaos G
author_sort Giavi, Stavroula
collection PubMed
description Asthma is a chronic inflammatory disease of the airways and is a big burden worldwide. It affects both children and adults, but it is insufficiently studied in adolescents, although this age group has important peculiarities and is challenging to treat, due to, but not exclusively because of, lack of adherence to treatment instructions. Evidence-based guidelines for the treatment of asthma targeting specifically adolescents are lacking, due to the fact that most studies are conducted either on children or in adults. Exercise-induced asthma occurs commonly in adolescents, leading to impaired physical activity. This review describes current treatment options for asthma in adolescents, focusing on leukotriene receptor antagonists, both as a monotherapy and as an add-on therapy for optimal asthma control.
format Online
Article
Text
id pubmed-3915976
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39159762014-03-05 Asthma control in adolescents: role of leukotriene inhibitors Giavi, Stavroula Papadopoulos, Nikolaos G Adolesc Health Med Ther Review Asthma is a chronic inflammatory disease of the airways and is a big burden worldwide. It affects both children and adults, but it is insufficiently studied in adolescents, although this age group has important peculiarities and is challenging to treat, due to, but not exclusively because of, lack of adherence to treatment instructions. Evidence-based guidelines for the treatment of asthma targeting specifically adolescents are lacking, due to the fact that most studies are conducted either on children or in adults. Exercise-induced asthma occurs commonly in adolescents, leading to impaired physical activity. This review describes current treatment options for asthma in adolescents, focusing on leukotriene receptor antagonists, both as a monotherapy and as an add-on therapy for optimal asthma control. Dove Medical Press 2010-10-06 /pmc/articles/PMC3915976/ /pubmed/24600268 http://dx.doi.org/10.2147/AHMT.S7600 Text en © 2010 Giavi and Papadopoulos, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Giavi, Stavroula
Papadopoulos, Nikolaos G
Asthma control in adolescents: role of leukotriene inhibitors
title Asthma control in adolescents: role of leukotriene inhibitors
title_full Asthma control in adolescents: role of leukotriene inhibitors
title_fullStr Asthma control in adolescents: role of leukotriene inhibitors
title_full_unstemmed Asthma control in adolescents: role of leukotriene inhibitors
title_short Asthma control in adolescents: role of leukotriene inhibitors
title_sort asthma control in adolescents: role of leukotriene inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915976/
https://www.ncbi.nlm.nih.gov/pubmed/24600268
http://dx.doi.org/10.2147/AHMT.S7600
work_keys_str_mv AT giavistavroula asthmacontrolinadolescentsroleofleukotrieneinhibitors
AT papadopoulosnikolaosg asthmacontrolinadolescentsroleofleukotrieneinhibitors